Data analysis software provider Celebrus Technologies (LON: CLBS) reported a rise in full year pre-tax profit from $7.4m to $8.4m, although it is likely to be loss making this year. That is du to the switch to a subscription model. The share price improved 11.9% to 165p.
Premier African Minerals (LON: PREM) shares rose a further following yesterday’s announcement that the Zulu lithium plant restarted on 6 July and optimisation of production will follow. The share price recovered 11.1% to 0.015p.
Begbies Traynor (LON: BEG) has launched a buyback of up to one million shares on the back of its full year results announcement. This shows the confidence in cash generation. Pre-tax profit was 7% ahead at £23.5m. Net cash was £900,000 at the end of April 2025. Total future earn out payments are £12.2m. Insolvencies remain relatively high compared with recent years. Growth is offsetting the increases in costs. There are headwinds for property advisory. Pre-tax profit could rise to £24.2m this year without further acquisitions. The share price increased 8.11% to 120p.
Jonathan Swann has increased his stake in Bezant Resources (LON: BZT) from 4.07% to 5.19%. The share price rose 6.52% to 0.049p.
FALLERS
Active Energy Group (LON: AEG) has closed a substantially oversubscribed placing raising £346,180. The biomass-based renewable energy technology developer will use the cash for working capital. The company is evaluating a digital assets strategy for its treasury management. A proportion of the fundraising is likely to be invested in Bitcoin and other digital assets. The share price slumped 32.9% to 0.235p.
Synergia Energy (LON: SYN) says Selan Exploration, its partner in the Cambay PSC, has contracted a workover rig for the C-64 well. Synergia Energy plans to sell its 50% stake in the Cambay PSC to Selan Exploration for an initial payment of $500,000 followed by $6.5m when the Indian government approves the deal. Then, 12 months later, the final $7m will be paid. The share price lost some of last week’s gains and is 10% lower at 0.0225p.
Optima Health (LON: OPT) mentioned a slight slowdown in new business revenues commencing in the second half when it reported results for the year to March 2025. The falling off of two contracts meant that revenues declined to £105m, while pe-tax profit fell from £13.4m to £12.8m. Panmure Liberum has trimmed forecast revenues for this year, and the pre-tax profit estimate has been reduced from £14.1m to £12.9m. The share price fell 8.53% to 193p.